Immix Biopharma (IMMX) Net Cash Flow (2021 - 2026)

Quarterly results put Net Cash Flow at -$14.7 million for Q1 2026, down 736.67% from a year ago — trailing twelve months through Mar 2026 was $62.2 million (up 564.44% YoY), and the annual figure for FY2025 was $76.2 million, up 43272.74%.

Immix Biopharma has reported Net Cash Flow over the past 6 years, most recently at -$14.7 million for Q1 2026.

  • Net Cash Flow reached -$14.7 million in Q1 2026 per IMMX's latest filing, down from $78.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $78.0 million in Q4 2025 and bottomed at -$14.7 million in Q1 2026.
  • Median Net Cash Flow over the past 5 years was -$1.8 million (2025), compared with a mean of $3.6 million.
  • The largest annual shift saw Net Cash Flow plummeted 2016.24% in 2022 before it skyrocketed 4032.39% in 2025.
  • Over 5 years, Net Cash Flow stood at -$3.5 million in 2022, then skyrocketed by 39.54% to -$2.1 million in 2023, then grew by 5.73% to -$2.0 million in 2024, then surged by 4032.39% to $78.0 million in 2025, then tumbled by 118.8% to -$14.7 million in 2026.
  • Business Quant data shows Net Cash Flow for IMMX at -$14.7 million in Q1 2026, $78.0 million in Q4 2025, and $4.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 2.44 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 625.70 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 457.40 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -152.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 60.68 Mn
10 Immix Biopharma 476.17 Mn 476.17 Mn - -14.67 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -14.67 Mn
Mar 31, 2026 -14.67 Mn
Dec 31, 2025 77.99 Mn
Dec 31, 2025 77.99 Mn
Sep 30, 2025 4.33 Mn
Sep 30, 2025 4.33 Mn
Jun 30, 2025 -5.44 Mn
Jun 30, 2025 -5.44 Mn
Mar 31, 2025 -1.75 Mn
Mar 31, 2025 -1.75 Mn
Dec 31, 2024 -1.98 Mn
Dec 31, 2024 -1.98 Mn
Sep 30, 2024 -4.31 Mn
Sep 30, 2024 -4.31 Mn
Jun 30, 2024 -5.35 Mn
Jun 30, 2024 -5.35 Mn
Mar 31, 2024 11.82 Mn
Mar 31, 2024 11.82 Mn
Dec 31, 2023 -2.10 Mn
Dec 31, 2023 -2.10 Mn
Sep 30, 2023 6.98 Mn
Sep 30, 2023 6.98 Mn
Jun 30, 2023 1.18 Mn
Jun 30, 2023 1.18 Mn
Mar 31, 2023 -1.97 Mn
Mar 31, 2023 -1.97 Mn
Dec 31, 2022 -3.48 Mn
Dec 31, 2022 -3.48 Mn
Sep 30, 2022 -1.46 Mn
Sep 30, 2022 -1.46 Mn
Jun 30, 2022 -653,029.00
Jun 30, 2022 -653,029.00
Mar 31, 2022 1.42 Mn
Mar 31, 2022 1.42 Mn
Dec 31, 2021 17.61 Mn
Dec 31, 2021 17.61 Mn
Sep 30, 2021 -69,108.00
Sep 30, 2021 -69,108.00
Jun 30, 2021 -75,681.00
Jun 30, 2021 -75,681.00
Mar 31, 2021 -202,248.00
Mar 31, 2021 -202,248.00